Acesion Pharma is a clinical-stage pharmaceutical company based in Frederiksberg, Denmark, developing novel therapies for atrial fibrillation (AF), the most common cardiac arrhythmia. The company pioneers small-molecule SK ion channel inhibition as a differentiated mechanism to treat AF safely and effectively. - View it on GitHub